The NRC and AP&C develop way to test quality of powders in 3D printing
The National Research Council of Canada (NRC) and AP&C, a GE Additive company, develop a new way to test the quality of powders used in […]
Pharmaceutical
Advanced bioanalytical technologies accelerate drug development in the new age of protein therapeutics
In 1986, the FDA approved a new transplant rejection drug that was derived from an intact monoclonal antibody (mAb).1 Although it would be almost a […]
Appili Therapeutics plans to use data from clinical study for a New Drug Application
Halifax-based Appili Therapeutics Inc. announces that they have received positive top-line results from a pivotal relative bioavailability study evaluating pharmacokinetics, safety, and palatability of ATI-1501 […]
PlantForm collaborates to manufacture biosimilar to the South African market
Guelph-based PlantForm Corporation of Canada is stretching across the ocean to collaborate with South Africa’s Council for Scientific and Industrial Research (CSIR) and BGM Pharmaceuticals […]
Gilead Sciences Canada recieves approval of Biktarvy for treating HIV-1 Infection
Health Canada grants Gilead Sciences Canada Inc. a Notice of Compliance for Biktarvy (bictegravir), a once-daily single tablet regimen (STR) for the treatment of HIV-1 […]
Lonza launches new bioscience website to support the work of scientists
Lonza launches its new bioscience website that is chalked full of detailed application and product information. The website has been designed to support the work […]
Knight Therapeutics brings Probuphine to Canada for opioid dependence
Knight Therapeutics Inc., a leading Canadian specialty pharmaceutical company, announces that Health Canada has approved Probuphine (buprenorphine subdermal implant) for the management of opioid dependence […]
Mylan proposes a biosimilar of BOTOX to market
Mylan N.V. and Revance Therapeutics, Inc. announce a global collaboration and license agreement for the development and commercialization of a proposed biosimilar to BOTOX (onabotulinumtoxinA). BOTOX […]
Helix BioPharma to present poster at the IASLC 18th Annual Targeted Therapies of Lung Cancer Meeting
Helix BioPharma will be presenting February 24, 2018, at the IASLC 18th Anual Targeted Therapies of Lung Cancer Meeting in Santa Monica. The Richmond Hill […]
MillipreSigma introduces the Viresolve Barrier capsule filters to its portfolio
MilliporeSigma introduces the Viresolve Barrier capsule filters to reduce the risk of bioreactor contamination. The filters are designed to remove viruses, mycoplasma and bacteria from cell culture media.